4-(溴乙酰基)苯氧基乙酸 | 29936-81-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-(溴乙酰基)苯氧基乙酸
• 中文别名: PTP抑制剂III
• 英文名称: p-(ω-Bromacetyl)phenoxiessigsaeure
• 英文别名: 4-(bromoacetyl)phenoxyacetic acid；2-[4-(2-bromoacetyl)phenoxy]acetic Acid
• CAS: 29936-81-0
• 化学式: C₁₀H₉BrO₄
• 分子量: 273.083
• InChiKey: RLSUZPAAQRBGTM-UHFFFAOYSA-N

物化性质

• 溶解度：
  溶于 DMSO (25 mg/ml)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(溴乙酰基)苯氧基乙酸 在 N,N'-二环己基碳二亚胺 作用下， 生成 (S)-2-[(S)-2-(2-{2-[4-(2-Bromo-acetyl)-phenoxy]-acetylamino}-acetylamino)-5-guanidino-pentanoylamino]-5-guanidino-pentanoic acid
  参考文献：
  名称：

  α-Bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure–Activity relationship

  摘要：

  A series of alpha-haloacetophenone derivatives was tested for inhibition of protein tyrosine phosphatases SHP-1 and PTP1B. The results show that the bromides are much more potent than the corresponding chlorides, whereas the phenyl ring is remarkably tolerant to modifications. Derivatization of the phenyl ring with a tripeptide Gly-Glu-Glu resulted in a potent, selective inhibitor against PTP1B. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00681-9
• 作为产物：
  描述：

  4-乙酰苯氧基乙酸 、 溴 在 乙醚 作用下， 以 溶剂黄146 为溶剂， 反应 64.0h， 以to provide 2-(4-(2-bromoacetyl)phenoxy)acetic acid (1.82 g) as a light brown solid的产率得到4-(溴乙酰基)苯氧基乙酸
  参考文献：
  名称：

  Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides

  摘要：

  本发明涉及公式I的化合物，以及在治疗中枢和外周神经系统的神经元疾病中使用公式I的化合物作为神经保护剂。公式I：

  公开号：

  US20070238768A1

文献信息

• [EN] DERIVATIVES OF THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES<br/>[FR] DERIVES D'INHIBITEURS DE THIAZOLE ET DE THIADIAZOLE DE TYROSINE PHOSPHATASES
  申请人：CENGENT THERAPEUTICS INC

  公开号：WO2006028970A1

  公开（公告）日：2006-03-16

  Provided herein are compounds and compositions for modulation of tyrosine phosphatase activity. In one embodiment, compounds and compositions for inhibiting protein tyrosine phosphatase activity are provided. In another embodiment, provided herein are compounds and compositions that are useful in the treatment, prevention, or amelioration of one or more symptoms of diseases caused by dysfunctional signal transduction, or in which dysfunctional signal transduction is implicated. In another embodiment, provided herein are compounds and compositions for treatment, prevention, or amelioration of one or more symptoms of diabetes. The compounds have following formulas: (II), (I), (III), and (IV).

  提供了一种用于调节酪氨酸磷酸酶活性的化合物和组合物。在一个实施例中，提供了用于抑制蛋白酪氨酸磷酸酶活性的化合物和组合物。在另一个实施例中，提供了用于治疗、预防或改善由信号转导功能障碍引起的一种或多种症状的疾病，或其中信号转导功能障碍涉及的疾病。在另一个实施例中，提供了用于治疗、预防或改善糖尿病的一种或多种症状的化合物和组合物。这些化合物的公式如下：(II)，(I)，(III)和(IV)。
• .alpha.-Amino ketone derivatives
  申请人：Imperial Chemical Industries Limited

  公开号：US04105790A1

  公开（公告）日：1978-08-08

  The invention concerns .alpha.-aminoacyl derivatives of phenyl-, phenoxy-, thiophenoxy- and phenylsulphinylalkanoic acids together with their amides, esters and pharmaceutically acceptable salts; processes for their preparation; and pharmaceutical compositions for therapeutic use in inhibiting the formation of thrombi and also in reducing the persistence of thrombi formed in the blood of warm blooded animals. Representative compounds of the invention are methyl 4-(aminoacetyl)phenoxyacetate, 4-(aminoacetyl)phenoxyacetic acid and methyl 4-(aminoacetyl)-thiophenoxyacetate, preferably as their hydrochlorides.

  该发明涉及苯基、苯氧基、硫代苯氧基和苯基磺基烷酸的α-氨基酰衍生物，以及它们的酰胺、酯和药用盐；它们的制备方法；以及用于在温血动物的血液中抑制血栓形成并减少已形成血栓持续存在的治疗用药物组合物。该发明的代表性化合物包括甲基4-(氨基乙酰)苯氧乙酸酯、4-(氨基乙酰)苯氧乙酸和甲基4-(氨基乙酰)-硫代苯氧乙酸酯，最好以它们的盐酸盐形式。
• [EN] N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] COMPOSÉS N-HYDROXY-NAPHTALÈNE DICARBOXAMIDE ET N-HYDROXY-BIPHÉNYL-DICARBOXAMIDE COMME INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
  申请人：MERCK & CO INC

  公开号：WO2009045385A1

  公开（公告）日：2009-04-09

  The present invention relates to a novel class of N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives. The N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds can be used to treat cancer. The N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of the N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives in vivo.

  本发明涉及一类新型的N-羟基-萘二甲酰胺和N-羟基联苯二甲酰胺衍生物。N-羟基-萘二甲酰胺和N-羟基联苯二甲酰胺化合物可用于治疗癌症。N-羟基-萘二甲酰胺和N-羟基联苯二甲酰胺化合物还可以抑制组蛋白去乙酰化酶，并适用于选择性诱导末端分化、阻止肿瘤细胞生长和/或凋亡，从而抑制这些细胞的增殖。因此，本发明的化合物可用于治疗具有肿瘤细胞增殖特征的患者。本发明的化合物也可用于预防和治疗TRX介导的疾病，如自身免疫、过敏和炎症性疾病，以及中枢神经系统（CNS）疾病的预防和/或治疗，如神经退行性疾病。本发明还提供包含N-羟基-萘二甲酰胺和N-羟基联苯二甲酰胺衍生物的制药组合物和这些制药组合物的安全用量方案，易于遵循，并在体内产生治疗有效量的N-羟基-萘二甲酰胺和N-羟基联苯二甲酰胺衍生物。
• Solid phase synthesis supports and methods
  申请人：3M Innovative Properties Company

  公开号：US20020173051A1

  公开（公告）日：2002-11-21

  Functionalized supports and methods for solid phase synthesis. Preferably, the functionalized support is azlactone-functionalized.

  功能化支撑物和固相合成方法。最好的是，功能化支撑物是氮杂环丙酮功能化的。
• Thiazole and thiadiazole inhibitors of tyrosine phosphatases
  申请人：Cheruvallath S. Zacharia

  公开号：US20060194768A1

  公开（公告）日：2006-08-31

  Compounds and compositions are provided for modulating the activity of protein tyrosine phosphatases. In one embodiment, the compounds and compositions are thiazoles and thiadiazoles that inhibit the activity of protein tyrosine phosphatase 1B.

  本发明提供了用于调节蛋白酪氨酸磷酸酶活性的化合物和组合物。在一种实施方式中，所述化合物和组合物是噻唑和噻二唑，可抑制蛋白酪氨酸磷酸酶1B的活性。